HOME
ABOUT THE COMPANY
Company Overview
Message from CEO
Management Team
Enterprise Video
INNOVATION
Pipeline
Focus Areas
Pipeline2
INVESTORS
Fact Sheet
Corporate Governance
Public Disclosure
Financial Report
Announcements and Circulars
Presentations and Webcasts
IR Contact
Analyst List
MEDIA
CONTACT
Contact
Career
菜单
中文
|
EN
HOME
ABOUT THE COMPANY
Company Overview
Message from CEO
Management Team
Enterprise Video
Innovation
Innovation
Pipeline
Focus Areas
Pipeline2
INVESTORS
Fact Sheet
Corporate Governance
Financial Report
Announcements and Circulars
Presentations and Webcasts
Analyst List
IR Contact
MEDIA
CONTACT
Contact
Career
中欧体育提示
本内容仅供医学专业人士使用。如果您是医学专业人士,请点击确认,进入页面;否则请点击退出,返回上一页。
确定
取消
Home
/
Media
Press Release
Media Report
2020
2024
2023
2022
2021
2020
2020-12-29
中欧体育治疗过敏性结膜炎药物OT-1001(Zerviate)Ⅲ期临床试验首例受试者入组
2020-12-28
中欧体育OT-401(Yutiq)正式入围海南省药监局真实世界研究试点名单
2020-12-01
中欧体育OT-401(Yutiq)在海南博鳌超级医院启动真实世界研究
2020-11-17
中欧体育荣膺由格隆汇主办2020大中华区最佳上市公司“年度最受关注IPO” 大奖
2020-11-11
OT-301(NCX470)第二项Ⅲ期临床(Denali试验)在美国完成首例受试者入组
2020-10-30
中欧体育与绿叶制药携手推进OT-702(阿柏西普生物类似药)研发及商业化
2020-10-23
中欧体育OT-301(NCX470)在中国正式获批III期临床,拟用于降低开角型青光眼或高眼压症患者的眼内压
2020-09-22
中欧体育OT-1001(ZERVIATE)在中国正式获批Ⅲ期临床试验
2020-09-21
中欧体育OT-1001(ZERVIATE)在中国正式获批Ⅲ期临床试验
2020-07-10
Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange
Follow us